Kinerase Pro+Therapy Cream with Kinetin & Zeatin 2.8 Ounces (80g) Tube
You looking to find the "Kinerase Pro+Therapy Cream with Kinetin & Zeatin 2.8 Ounces (80g) Tube" Good news! You can purchase Kinerase Pro+Therapy Cream with Kinetin & Zeatin 2.8 Ounces (80g) Tube with secure price and compare to view update price on this product. And deals on this product is available only for limited time.
Product Description
A professionals-only skin care line, Kinerase Pro+Therapy Cream with the combination of kinetin and zeatin works to help improve the appearance of fine lines and wrinkles. It also helps improve the appearance of skin texture, tone, and blotchiness in sun damaged skin, while gently moisturizing dry and sensitive or post-procedure skin. Studies have shown that zeatin improves the appearance of fine lines and wrinkles, skin roughness, and hyperpigmentation and only zeatin has also been clinically shown to improve the appearance of the more severe signs of skin aging after only 8 weeks.
Product Details
- Amazon Sales Rank: #71341 in Beauty
- Size: 80 g
- Color: white
- Brand: Kinerase
- Model: 416j7
- Published on: 2011-02-16
- Released on: 2008-02-27
- Ingredients: Water, Glyceryl Stearate, Isopropyl Palmitate, Propylene Glycol, Stearic Acid, Cetyl Alcohol, Carthamus Tinctorius (Safflower) Seed Oil, Glycine Soya (Soybean) Stearols, Stearyl Alochol, Laureth-23, Dimethicone, Citric Acid, Sodium Hydroxide, Soluble Collagen, Kinetin, Zeatin, Carbomer, Panthenol, Ascorbic Acid, Hydrolized Elastin, Aloe Barbadensis Leaf Juice, Imidazolidinyl Urea, Triethanolamine, Methylparaben, Propylparaben
- Number of items: 1
- Dimensions: 6.80" h x2.20" w x2.20" l,
Features
- Contains Kinetin and Zeatin which provides superior moisturization and repair benefits for aging skin
- Improves skin moisture retention by 26% in 24 weeks
- Minimizes appearance of freckles and brown spots
- Ideal for sensitive skin including skin conditions like dermatitis, eczema and rosacea
- Non-Comedogenic and Hypoallergenic
ไม่มีความคิดเห็น:
แสดงความคิดเห็น